HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

carboxycinnamic acid bishydroxamide

inhibits histone decacetylase I & 3; structure in first source

Also Known As:

CBHA cpd; m-carboxycinnamic acid bishydroxamide

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Cinnamates: 48
      - carboxycinnamic acid bishydroxamide: 1

Experts

1.	Fandy, Tamer E: 1 article (12/2005)
2.	Luetrakul, Thitidaj: 1 article (12/2005)
3.	Ross, Douglas D: 1 article (12/2005)
4.	Shankar, Sharmila: 1 article (12/2005)
5.	Singh, Thiyam R: 1 article (12/2005)
6.	Srivastava, Rakesh K: 1 article (12/2005)

Related Diseases

1.	Leukemia 12/01/2005 - "In the present study, we aimed to elucidate the mechanism responsible for the interactive effects of histone deacetylase (HDAC) inhibitors [suberoylanilide hydroxamic acid (SAHA), MS-275, m-carboxycinnamic acid bishydroxamide (CBHA), and trichostatin-A (TSA)] and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on apoptosis in leukemia cells. "

Related Drugs and Biologics

1.	Histone Deacetylase Inhibitors
2.	TNF-Related Apoptosis-Inducing Ligand
3.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4.	Histone Deacetylases (Histone Deacetylase)
5.	Vorinostat
6.	theasinensin A
7.	entinostat (MS 275)
8.	trichostatin A (A 300)